CERNARO, Valeria
 Distribuzione geografica
Continente #
NA - Nord America 6.625
EU - Europa 6.272
AS - Asia 3.331
SA - Sud America 989
Continente sconosciuto - Info sul continente non disponibili 276
AF - Africa 106
OC - Oceania 14
Totale 17.613
Nazione #
US - Stati Uniti d'America 6.433
RU - Federazione Russa 3.467
SG - Singapore 1.262
CN - Cina 1.010
BR - Brasile 836
IE - Irlanda 707
SE - Svezia 595
IT - Italia 433
HK - Hong Kong 347
DE - Germania 252
VN - Vietnam 199
FR - Francia 187
PL - Polonia 170
GB - Regno Unito 156
IN - India 124
FI - Finlandia 113
BD - Bangladesh 90
CA - Canada 86
AR - Argentina 56
TR - Turchia 52
MX - Messico 46
IQ - Iraq 39
ZA - Sudafrica 34
EC - Ecuador 31
ES - Italia 26
BE - Belgio 25
PK - Pakistan 25
JP - Giappone 24
NL - Olanda 23
CO - Colombia 21
CZ - Repubblica Ceca 20
ID - Indonesia 20
JM - Giamaica 19
UZ - Uzbekistan 19
UA - Ucraina 18
AT - Austria 17
KE - Kenya 16
VE - Venezuela 14
MA - Marocco 13
AE - Emirati Arabi Uniti 12
SA - Arabia Saudita 12
AU - Australia 10
AZ - Azerbaigian 9
EG - Egitto 9
PH - Filippine 9
PY - Paraguay 9
CH - Svizzera 8
CL - Cile 8
KG - Kirghizistan 8
MY - Malesia 8
NP - Nepal 8
AL - Albania 7
CI - Costa d'Avorio 7
IL - Israele 7
PE - Perù 7
TN - Tunisia 7
TT - Trinidad e Tobago 7
DO - Repubblica Dominicana 6
HN - Honduras 6
BG - Bulgaria 5
DK - Danimarca 5
DZ - Algeria 5
ET - Etiopia 5
EU - Europa 5
GT - Guatemala 5
NO - Norvegia 5
PS - Palestinian Territory 5
AM - Armenia 4
CR - Costa Rica 4
JO - Giordania 4
LT - Lituania 4
LV - Lettonia 4
NZ - Nuova Zelanda 4
RO - Romania 4
BH - Bahrain 3
BY - Bielorussia 3
GE - Georgia 3
GR - Grecia 3
KR - Corea 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
NI - Nicaragua 3
TW - Taiwan 3
AO - Angola 2
BB - Barbados 2
BN - Brunei Darussalam 2
BO - Bolivia 2
EE - Estonia 2
GP - Guadalupe 2
GY - Guiana 2
HU - Ungheria 2
KZ - Kazakistan 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
SR - Suriname 2
Totale 17.320
Città #
Ashburn 1.100
Moscow 951
Dallas 707
Dublin 705
Singapore 689
Chandler 572
San Jose 461
Hong Kong 344
Beijing 332
Nyköping 332
New York 171
Council Bluffs 162
The Dalles 161
Warsaw 157
Los Angeles 154
Munich 113
Dearborn 112
Boardman 109
Jacksonville 104
Princeton 104
Lauterbourg 95
Medford 93
Ann Arbor 90
Messina 80
Des Moines 75
Cambridge 72
São Paulo 68
Ho Chi Minh City 64
Santa Clara 59
Jinan 55
Houston 51
Shenyang 49
Tianjin 49
Bremen 44
Redondo Beach 44
Hanoi 43
Buffalo 42
Frankfurt am Main 41
Hyderabad 40
San Mateo 40
Orem 38
Turku 37
Brooklyn 32
Seattle 32
Montreal 29
Pune 29
Wilmington 28
Lancaster 27
Guangzhou 26
Phoenix 26
Rome 26
Catania 25
Rio de Janeiro 25
Chicago 24
Denver 24
Brussels 22
Johannesburg 22
Nanjing 22
Atlanta 20
Mexico City 20
Tokyo 20
Hebei 19
Manchester 19
Stockholm 19
Belo Horizonte 18
Curitiba 17
London 17
Poplar 17
San Francisco 17
Toronto 17
Ankara 16
Brasília 16
Haikou 16
Hangzhou 16
Milan 16
Baghdad 15
Brno 15
Kingston 15
Ningbo 15
Tashkent 15
Chennai 14
Columbus 14
Philadelphia 14
Düsseldorf 13
Naples 13
Shanghai 13
Amsterdam 12
Jiaxing 12
Lentini 12
Nairobi 12
Palermo 12
Campinas 11
Istanbul 11
Miami 11
Najaf 11
Nuremberg 11
Taizhou 11
Wroclaw 11
Zhengzhou 11
Calgary 10
Totale 9.842
Nome #
Marked improvement of thyroid function and autoimmunity by Aloe barbadensis miller juice in patients with subclinical hypothyroidism 407
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 262
[Periorbital purpura: a pathognomonic but late sign of AL amyloidosis] / Porpora periorbitaria: un segnale patognomonico ma tardivo di amiloidosi AL 255
[Lupus Nephritis and Enteritis, a dual simultaneous involvement with Arteriolar Thrombosis] 241
[Complement factor B mutation in atypical hemolytic uremic syndrome. Rare cause of rare disease] 237
[From hyponatremia to tolvaptan] 236
Metformin-related lactic acidosis: is it a myth or an underestimated reality? 233
Auxine: thermodynamic properties, complexing ability and dosage in human serium 227
ANTI-INFLAMMATORY ACTION OF DENOSUMAB IN VIVO AND IN VITRO 223
[From oxygen to erythropoietin, as a protagonist of the skin-brain-kidney axis]. 221
[Long-term outcome of renal function in women with preeclampia and pregestational diabetes] 217
Mortalità e morbidità dei pazienti dializzati in Sicilia: studio epidemiologico analitico sul confronto tra metodiche convettive e diffusive 214
Sclerostin levels in uremic patients: a link between bone and vascular disease 213
Antioxidant agents for delaying diabetic kidney disease progression: A systematic review and meta-analysis 212
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failure 210
Auxin induces cell proliferation in an experimental model of mammalian renal tubular epithelial cells 210
Role of Paricalcitol in Modulating the Immune Response in Patients with Renal Disease 203
AKI - EXPERIMENTAL MODELS 201
Down with the erythropoietin. Long live the erythropoietin! 199
Fibrosis, regeneration and cancer: what is the link? 195
The Myth of Water and Salt: From Aquaretics to Tenapanor 195
Delayed graft function and chronic allograft nephropathy: Diagnostic and prognostic role of neutrophil gelatinase-associated lipocalin 189
Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study 184
A new therapy for kidney injury: regeneration. 183
Kidney disease and psoriasis: novel evidences beyond old concepts 182
Beneficial effects of oral pure caffeine on oxidative stress 180
Before and after preeclampsia: What biomarkers are there? 175
Relaxin: New Pathophysiological Aspects and Pharmacological Perspectives for an Old Protein. 173
Convective Dialysis Reduces Mortality Risk: Results From a Large Observational, Population-Based Analysis 173
Apelin, Plasmatic Osmolality and Hypotension in Dialyzed Patients. 172
Opposite actions of urotensin II and relaxin-2 on cellular expression of fibronectin in renal fibrosis: A preliminary experimental study 172
Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis 172
Erythropoietin and the truths of science. 171
Negative Emotions in End-Stage Renal Disease: Are Anxiety Symptoms Related to Levels of Circulating Catecholamines? 170
Lipid disorders in patients with renal failure: Role in cardiovascular events and progression of chronic kidney disease 168
Kidney biopsy in type 2 diabetic patients: Critical reflections on present indications and diagnostic alternatives 168
Renoprotective effect of erythropoietin in zebrafish after administration of gentamicin: an immunohistochemical study for β-catenin and c-kit expression 165
Vascular access for hemodialysis: current perspectives 163
Nephro-oncology: a link in evolution 163
L’ERITROPOIETINA HA AZIONE NEFROPROTETTIVA IN UN MODELLO SPERIMENTALE DI ZEBRAFISH (DANIO RERIO) DOPO SOMMINISTRAZIONE DI GENTAMICINA 160
Antiproteinuric effect of DPP-IV inhibitors in diabetic and non-diabetic kidney diseases 160
Indole-3-acetic acid correlates with monocyte-to-high-density lipoprotein (HDL) ratio (MHR) in chronic kidney disease patients 160
Monocyte to HDL ratio: a novel marker of resistant hypertension in CKD patients 159
Semaphorin 3A serum levels are influenced by haemodialysis: what clinical significance? 159
The relationship between coping, emotion regulation, and quality of life of patients on dialysis 159
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic review 159
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney Disease 158
COMPARISON OF SEVELAMER, SEVELAMER CARBONATE AND LANTHANIUM CARBONATE IN VITRO AND IN VIVO 158
L'AUXINA INDUCE PROLIFERAZIONE CELLULARE IN UN MODELLO SPERIMENTALE DI CELLULE EPITELIALI TUBULARI RENALI 158
Salt-water imbalance and fluid overload in hemodialysis patients: a pivotal role of corin 157
Stress-induced hashitoxicosis: Case report and relative HLA serotype and genotype 156
From water to aquaretics: a legendary route. 155
Erithropoietin exerts a renoprotective action in an experimental model of zebrafish (Danio Rerio) after administration of gentamicin 154
An overview of experimental and early investigational therapies for the treatment of polycystic kidney disease 154
Squilibri idrico-salini e sovraccarico di liquidi nei pazienti dializzati, il ruolo centrale di Corin 154
Kidney-lung connections in acute and chronic diseases: current perspectives 154
Xanthine oxidase inhibitors for improving renal function in chronic kidney disease patients: An updated systematic review and meta-analysis 153
Regenerative medicine: does Erythropoietin have a role? 152
Role of Vitamin D in Vascular Complications and Vascular Access Outcome in Patients with Chronic Kidney Disease 150
Cross-sectional evaluation of kidney function in hospitalized patients: estimated GFR versus renal scintigraphy 150
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 149
Autoimmunity and Infection in Glomerular Disease 147
Monoclonal antibodies for renal diseases: current concepts and ongoing treatments 147
Maternal and Fetal Outcomes of Pregnancy in Nephrotic Syndrome Due to Primary Glomerulonephritis 147
CIGARETTE SMOKE AND ENDOTHELIAL DYSFUNCTION: NGAL A NEW BIOMARKER 146
Proteinuric effect of transcranial magnetic stimulation in healthy subjects and diabetic patients with stage 3-4 CKD 145
New options for the management of polycystic kidney disease 143
SCLEROSTIN CAN BE A NEW "KEY PLAYER" IN VASCULARCALCIFICATION IN CKD? 142
Role of Vitamin D Status in Diabetic Patients with Renal Disease 142
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus 142
Complement Inhibition Therapy and Dialytic Strategies in Paroxysmal Nocturnal Hemoglobinuria: The Nephrologist's Opinion 142
COMPARISON OF FORMULAS TO ESTIMATE THE GLOMERULAR FILTRATION RATE WITH THAT OF SCINTIGRAPHY EVALUATION OF KIDNEY FUNCTION IN HOSPITALIZED PATIENTS 139
Erythropoiesis and chronic kidney disease–related anemia: From physiology to new therapeutic advancements 139
Renal biopsy: Still a landmark for the nephrologist 138
Novel avenues for treating diabetic nephropathy: new investigational drugs 138
QUANTITATIVE ULTRASOUND OF BONE AND HANDGRIP STRENGTH ARE RELATED TO FRACTURE RISK IN HEMODIALYSIS PATIENTS 135
Unexpected hypercalcemia in a diabetic patient with kidney disease 132
Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study 131
NGAL AND ANESTHETICS: PROTECTIVE ROLE OF SEVOFLURANE 130
Does Erythropoietin Always Win? 128
FP042AUXIN INDUCES CELL PROLIFERATION IN AN EXPERIMENTAL MODEL OF MAMMALIAN RENAL TUBULAR EPITHELIAL CELLS 128
Protective role of vitamin d in renal tubulopathies 126
Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker? 122
Maternal peripheral blood CD34+ cells for prediction of fetal kidney malformations: results from a case-control analysis 121
NGAL is a precocious marker of therapeutic response. 120
NEW MARKERS OF VASCULAR AND CARDIAC DYSFUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) 118
Exploring the effects of DPP-4 inhibitors on the kidney from the bench to clinical trials 113
Commonly used immunosuppressive drugs for kidney diseases and pregnancy: focus on open questions 108
Endothelial progenitor cells at the interface of chronic kidney disease: from biology to therapeutic advancement 107
Comparison between creatinine clearance and eGFRcyst-crea: a real-life experience 106
NGAL as an early biomarker of kidney disease in Joubert syndrome: three brothers compared. 106
Differences in Efficacy between Antibacterial Lock Therapy and the Standard of Care for CVC-Related Infections: A Systematic Review and Meta-Analysis 104
New Insights on the Role of Vitamin D in the Progression of Renal Damage 101
Clinical evaluation of the safety, efficacy and tolerability of lanthanum carbonate in the management of hyperphosphatemia in patients with end-stage renal disease 99
Review and Practical Excursus of the Propensity Score: Low Protein Diet Compared to Mediterranean Diet in Patients With Chronic Kidney Disease 99
UROTENSIN AND RELAXIN: OPPOSITE ACTIONS AND POTENTIAL THERAPEUTIC APPLICATIONS IN RENAL FIBROSIS 97
Immune Checkpoint Inhibitors and the Kidney: A Focus on Diagnosis and Management for Personalised Medicine 96
Hyperphosphatemia in Chronic Kidney Disease: The Search for New Treatment Paradigms and the Role of Tenapanor 95
The future of phosphate binders: a perspective on novel therapeutics 95
Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide 94
Totale 16.170
Categoria #
all - tutte 58.461
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.461


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022695 0 0 0 48 46 8 50 32 7 171 102 231
2022/20232.054 145 228 87 153 163 189 9 121 877 14 52 16
2023/2024605 37 54 27 42 51 192 18 26 5 59 11 83
2024/20252.555 47 18 50 156 69 106 101 477 603 205 280 443
2025/20268.840 522 531 752 635 775 1.637 972 1.117 1.060 370 218 251
2026/20271.302 304 395 392 211 0 0 0 0 0 0 0 0
Totale 17.613